<DOC>
	<DOC>NCT01771081</DOC>
	<brief_summary>POLARIS : A non-interventional study in patients with diabetic macular edema (DME) with central involvement to assess the effectiveness of existing anti-vascular endothelial growth factor (anti-VEGF) treatment regimens.</brief_summary>
	<brief_title>Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Patients diagnosed with type 1 or 2 diabetes mellitus Patients diagnosed with DME with central involvement (defined as the area of the center subfield of optical coherence tomography [OCT]) Patients for whom the decision has been made to treat with an approved antiVEGF therapy prior to inclusion into the study Patients who received the first approved intravitreal anti VEGF treatment from October 01, 2012 Patients who give informed consent in writing for study participation Treatment with any antiVEGF therapy prior to the start of the observation period (October 01, 2012) or enrolment into the study Participation in an investigational program with interventions out of clinical routine practice</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Longitudinal Studies,</keyword>
	<keyword>Observation</keyword>
	<keyword>Epidemiology</keyword>
</DOC>